Fedja A. Rochling

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

Vincenzo Mazzaferro, Josep M. Llovet, Rosalba Miceli et al. · The Lancet Oncology · 2008 · 2K citations · Full text

Liver, Hepatology, Milan Criteria +8

Acetaminophen Toxicity in an Urban County Hospital

Frank Vinholt Schiødt, Fedja A. Rochling, Donna L. Casey et al. · New England Journal of Medicine · 1997 · 418 citations · Full text

Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study

David Jones, Pol Boudes, Mark G. Swain et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 181 citations

Molecular Pharmacology, Selective Ppar-δ Agonist, Hepatology +11

Unsedated transnasal EGD: an alternative approach to conventional esophagogastroduodenoscopy for documenting Helicobacter pylori eradication

Kia Saeian, William Townsend, Fedja A. Rochling et al. · Gastrointestinal Endoscopy · 1999 · 53 citations

Transnasal Egd, Esophagus, Gastroenterology +6

Maintenance of Parenteral Nutrition Volume Reduction, Without Weight Loss, After Stopping Teduglutide in a Subset of Patients With Short Bowel Syndrome

Charlene Compher, Richard Gilroy, M. Pertkiewicz et al. · Journal of Parenteral and Enteral Nutrition · 2011 · 51 citations · Full text